in

More than 110 drugs, capable of penetrating this elusive barrier are currently being evaluated for t

The concept of BBB penetration is anticipated to bring about a paradigm shift in modern healthcare. In fact, experts believe that there is an important relationship between the recent pandemic of Coronavirus disease (COVID-19) and cerebrovascular system, presenting commercial opportunities for players engaged in the development of BBB penetrating drugs.

 

To order this 400+ page report, which features 145+ figures and 205+ tables, please visit this link 

 

The USD 940 million (by 2030) financial opportunity within the BBB market has been analyzed across the following segments:

Type of Payment Model Adopted

  • Upfront payments
  • Milestone payments

Type of Molecule

Small Molecules

Biologics

Target Disease Indication

  • Brain Metastases in Breast Cancer
  • Glioblastoma Multiforme
  • Hunter Syndrome
  • Hurler Syndrome

Leading Technology Platforms

  • G®-Technology
  • J-Brain Cargo® Technology
  • LRP-1 Technology
  • Trojan Horse Technology

Leading Drug Developers

  • 2-BBB
  • Angiochem
  • ArmaGen
  • JCR Pharmaceuticals

Key Geographical Regions

North America

Europe

Asia-Pacific

 

The Blood-Brain Barrier (BBB) Market (2nd Edition), 2020-2030: Focus on Non-Invasive Drug Delivery Technology Platforms and Therapeutics report features the following companies, which we identified to be key players in this domain: 

  • Angiochem
  • ArmaGen
  • BioArctic
  • Cyclenium Pharma
  • Denali Therapeutics
  • ICB International
  • Iproteos
  • JCR Pharmaceuticals
  • Lauren Sciences
  • Medesis Pharma
  • Ossianix
  • Vect-Horus

 

Table of Contents

 

1. Preface

2. Executive Summary

3. Introduction

4. Market Landscape: Non-Invasive BBB Penetration

5. Market Landscape: BBB Penetrating Drugs

6. Company Profiles

7. Technology Competitiveness Analysis

8. Non-Invasive BBB Penetration Technologies: Popular Approaches 

9. Partnerships and Collaborations

10. Analysis of Recent Licensing Agreements

11. Funding and Investment Analysis

12. Patent Analysis

13. Drug Development Strategy Analysis

14. Market Potential of Key Neurological Disorders 

15. Likely Partner Analysis

 

16. Market Forecast

 

17. Conclusion

 

18. Executive Insights

19. Appendix 1: Tabulated Data

20. Appendix 2: List of Companies and Organizations

 

To purchase a copy, please visit https://www.rootsanalysis.com/reports/view_document/blood-brain-barrier-drug-delivery/310.html

 

Contact Details

Gaurav Chaudhary

+1 (415) 800 3415

gaurav.chaudhary@rootsanalysis.com 

This post was created with our nice and easy submission form. Create your post!

Leave a Reply

Your email address will not be published. Required fields are marked *

GIPHY App Key not set. Please check settings

What do you think?

The BBB penetrating drugs market is projected to grow at an annualized rate of ~154%, till 2030

The ‘Blood-Brain Barrier (BBB) Market, 2020-2030: Focus on Non-Invasive Drug Delivery Technology Pla